SLNSW-Efficacy and safety of tofacitinib monotherapy, t...-TN_cdi_proquest_journals_1924517237

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Full title: Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Author/creator: ORAL Strategy investigators, Fleischmann, Roy, Prof, Mysler, Eduardo, MD, Hall, Stephen, MD, Kivitz, Alan J, MD, Moots, Robert J, Prof, Luo, Zhen, PhD, DeMasi, Ryan, MD, Soma, Koshika, MD, Zhang, Richard, PhD, Takiya, Liza, PharmD, Tatulych, Svitlana, MD, Mojcik, Christopher, MD, Krishnaswami, Sriram, PhD, Menon, Sujatha, PhD, Smolen, Josef S, Prof.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1924517237

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1924517237

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

    Record identifier

    TN_cdi_proquest_journals_1924517237

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1924517237

    Share

    Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1924517237

    Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

    Full title

    Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

    Author / Creator

    ORAL Strategy investigators ; Fleischmann, Roy, Prof ; Mysler, Eduardo, MD ; Hall, Stephen, MD ; Kivitz, Alan J, MD ; Moots, Robert J, Prof ; Luo, Zhen, PhD ; DeMasi, Ryan, MD ; Soma, Koshika, MD ; Zhang, Richard, PhD ; Takiya, Liza, PharmD ; Tatulych, Svitlana, MD ; Mojcik, Christopher, MD ; Krishnaswami, Sriram, PhD ; Menon, Sujatha, PhD ; Smolen, Josef S, Prof

    Publisher

    England: Elsevier Ltd

    Journal title

    The Lancet (British edition), 2017, Vol.390 (10093), p.457-468

    Record Identifier

    TN_cdi_proquest_journals_1924517237

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adalimumab - administration & dosage Adalimumab - adverse effects Adalimumab - therapeutic use Administration, Oral Adult Analysis Antirheumatic Agents - administration & dosage Antirheumatic Agents - adverse effects Antirheumatic Agents - therapeutic use Arthritis Arthritis, Rheumatoid - drug therapy Care and treatment Clinical trials Double-Blind Method Drug Administration Schedule Drug dosages Drug therapy Drug Therapy, Combination Enzyme inhibitors Evidence-based medicine Female Humans Immunotherapy Internal Medicine Janus kinase Male Methotrexate Methotrexate - administration & dosage Methotrexate - adverse effects Methotrexate - therapeutic use Middle Aged Monoclonal antibodies Patients Pharmaceutical industry Piperidines - administration & dosage Piperidines - adverse effects Piperidines - therapeutic use Pyrimidines - administration & dosage Pyrimidines - adverse effects Pyrimidines - therapeutic use Pyrroles - administration & dosage Pyrroles - adverse effects Pyrroles - therapeutic use Rheumatism Rheumatoid arthritis Rheumatoid factor Rheumatology Safety Severity of Illness Index TNF inhibitors Treatment Outcome Tumor necrosis factor-TNF

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1924517237

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1924517237

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections